Viewing Study NCT03252808

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:57 AM
Ignite Modification Date: 2026-03-04 @ 7:02 AM
Study NCT ID: NCT03252808
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-12-09
First Post: 2017-08-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase I Study of TBI-1401(HF10) Plus Chemotherapy in Patients with Unresectable Pancreatic Cancer.
Sponsor: Takara Bio Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Cancer Stage III View
None Pancreatic Cancer Stage IV View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Unresectable pancreatic cancer View
None Metastatic pancreatic cancer View
None Pancreatic adenocarcinoma View
None TBI-1401(HF10) View
None HF10 View
None Oncolytic virus View
None Oncolytic viral immunotherapy View
None Gemcitabine View
None Nab-paclitaxel View
None Albumin-bound paclitaxel View
None Abraxane View
None Tegafur-gimeracil-oteracil potassium View
None TS-1 View
None canerpaturev View